JUNIPER PHARMACEUTICALS INC JNP Income Statement

Juniper pharmaceuticals inc (JNP)

Income statement / TTM

Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues
Product revenues
34,810	35,036	32,688	32,179	30,847	28,612	27,211	25,232	24,910	23,631	22,891	23,811	22,981	20,434	18,143	14,552	14,103	17,614	19,693	22,041	22,025	0	-	0	0	-	-	-	-	-	-
Product revenues from related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	167	0	0	0	-	-	-	-	-	0	-	-	-	-	-	-	-
Service revenues
20,550	19,220	17,291	15,606	14,346	13,333	13,065	13,223	13,104	12,444	11,651	10,196	9,356	8,752	8,770	7,610	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-
License revenues
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Royalties
-	-	-	-	-	-	14,297	3,813	3,691	3,653	3,745	3,841	6,055	6,227	5,599	4,764	1,617	672	395	396	396	0	-	0	0	-	-	-	-	-	-
Royalties from related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	714	1,625	2,513	3,350	3,436	3,429	0	0	-	0	-	-	-	-	-	-	-
Other revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	119	153	157	0	-	0	0	-	-	-	-	-	-
Total revenues
55,610	54,256	49,979	59,119	57,689	55,343	54,573	42,268	41,705	39,728	38,287	37,848	38,392	35,413	33,393	31,370	26,959	28,283	27,583	28,093	29,197	0	-	0	0	-	-	-	-	-	-
Cost of product revenues
21,571	20,716	19,013	18,479	17,002	15,881	15,595	14,120	14,629	13,968	13,053	13,533	12,724	11,156	10,470	10,244	9,609	10,487	10,903	10,310	10,280	0	-	0	0	-	-	-	-	-	-
Cost of product revenues from related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-
Cost of service revenues
11,327	10,715	9,948	9,217	8,680	8,618	8,698	8,815	9,154	8,918	8,361	7,916	7,272	7,139	7,219	5,970	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-
Total cost of revenues
32,898	31,431	28,961	27,696	25,682	24,499	24,293	22,935	23,783	22,886	21,414	21,449	19,996	18,295	17,689	17,579	15,718	14,680	13,250	12,098	13,325	0	-	0	0	-	-	-	-	-	-
Gross profit
22,712	22,825	21,018	31,423	32,007	30,844	30,280	19,333	17,922	16,842	16,873	16,399	18,396	17,118	15,704	13,791	11,241	13,603	14,333	15,994	15,871	0	-	0	0	-	-	-	-	-	-
Operating expenses
Sales and marketing
2,052	1,899	1,859	1,655	1,397	1,366	1,259	1,218	1,297	1,200	1,249	1,314	1,443	1,628	1,708	1,414	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-
Research and development
5,895	6,488	6,860	6,727	6,740	8,889	9,676	10,159	9,453	7,788	7,039	5,350	0	0	-	0	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-
Acquisition-related expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,623	0	0	0	-	-	-	-	-	-	-	-	-
General and administrative
16,967	15,053	15,385	16,514	16,387	15,027	14,066	12,917	12,026	11,344	10,458	9,107	9,035	8,712	8,589	8,995	8,441	8,512	8,039	7,783	8,113	0	-	0	0	-	-	-	-	-	-
Restructuring charge
-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
25,691	24,217	24,881	25,652	24,524	25,282	25,001	24,294	22,776	20,332	18,746	15,962	14,657	12,387	10,960	11,110	10,879	10,492	10,101	9,445	8,908	0	-	0	0	-	-	-	-	-	-
Loss from operations
-2,979	-1,392	-3,863	5,771	7,483	5,562	5,279	-4,961	-4,854	-3,490	-1,873	437	3,739	4,731	4,744	2,681	362	3,111	4,232	6,548	6,963	0	-	0	0	-	-	-	-	-	-
Interest expense, net
-146	-147	-130	-128	-105	-99	-97	-99	-102	-105	-106	-107	-109	-111	-118	-91	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of common stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-379	-808	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-
Interest (expense) income, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	-	-	-	-	-	-
Change in fair value of common stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	-	-	-	-	-	-
Other income, net
2,254	1,506	1,747	743	706	777	860	462	486	442	488	515	477	476	302	152	101	9	-14	-76	-110	0	-	0	0	-	-	-	-	-	-
Total non-operating income (expense)
0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-
Loss before income taxes
-871	-33	-2,246	6,386	8,084	6,240	6,042	-4,598	-4,470	-3,153	-1,491	3,125	2,910	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Loss) Income before income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	6,017	6,238	0	-	0	0	-	-	-	-	-	-
Income tax expense
114	-186	-186	-1	39	87	91	41	49	4	5	594	481	644	651	401	514	351	342	11	0	0	-	0	-	-	-	-	-	-	-
Net loss
-985	153	-2,060	6,387	8,045	6,153	5,951	-4,639	-4,519	-3,157	-1,496	250	3,626	4,522	4,656	3,010	984	3,651	4,741	8,248	6,918	6,204	9,917	11,703	29,628	0	0	0	-	-	-
Adjustments attributable to preferred stockholders
-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net (loss) income available to common stockholders
0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic net (loss) income per common share
-0.14	0.07	0.10	-0.13	0.01	-0.13	0.89	0.02	-0.21	-0.15	-0.09	0.03	-0.08	0.00	0.06	0.35	0.00	0.01	-0.08	0.15	0.24	0.11	-	0.04	0.02	-	-	-	-	-	-
Diluted net (loss) income per common share
-0.14	0.06	0.14	-0.13	-0.03	-0.13	0.89	0.02	-0.21	-0.15	-0.09	0.03	-0.08	0.00	0.06	0.35	-0.01	-0.01	-0.09	0.11	0.24	0.09	-	0.04	0.02	-	-	-	-	-	-
Basic weighted average common shares outstanding
11,103	10,943	10,846	10,844	10,803	10,803	10,803	10,799	10,789	10,789	10,815	10,771	10,758	10,752	10,739	10,749	10,741	11,739	12,055	11,138	10,927	10,916	-	10,916	87,305	-	-	-	-	-	-
Diluted weighted average common shares outstanding
11,103	12,287	10,695	10,844	10,954	10,803	10,926	11,060	10,789	10,789	10,358	11,009	10,758	10,971	10,750	10,758	10,756	11,764	11,649	11,293	11,077	11,073	-	11,067	88,483	-	-	-	-	-	-
Foreign currency translation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-
NET INCOME (LOSS)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Foreign currency translation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Unrealized gain (loss) on short term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-43	0	0	0	-
COMPREHENSIVE INCOME
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	21,760	13,160	0	0	0